MoleculeMind's New MMDesign Technical Report Demonstrates 94.7% Campaign Success Rate Across Diverse Molecular Targets and Modalities
SHANGHAI, Nov. 3, 2026 /PRNewswire/ -- MoleculeMind, an AI-native biological infrastructure company, recently released a new technical report detailing the performance of MMDesign, its AI-powered de novo molecular design platform which demonstrated a 94.7% campaign success rate across...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 80 stories mentioning NOV, the earliest published 19 Oct 2026.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.